ACCESSION: MSBNK-SMB_Measured-HSA001P0352004
RECORD_TITLE: Characterized; N-(11Z,14Z)-eicosadienoylethanolamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 17
COMMENT: RAW_SPEC {'16_posi_14354': {'bp': 598917.0, 'sum': 1953538.0}, '17_posi_14352': {'bp': 567990.0, 'sum': 1943100.0}, '15_posi_14355': {'bp': 482203.0, 'sum': 1745252.0}, '14_posi_14354': {'bp': 438005.0, 'sum': 1417195.0}, '3_posi_14352': {'bp': 335542.0, 'sum': 1175139.0}, '12_posi_14354': {'bp': 281181.0, 'sum': 992581.0}, 'BLK01_14373': {'bp': 255334.0, 'sum': 949853.0}, '10_posi_14356': {'bp': 232957.0, 'sum': 843074.0}, '13_posi_14354': {'bp': 220798.0, 'sum': 846494.0}, '4_posi_14353': {'bp': 215260.0, 'sum': 816150.0}, '2_posi_14352': {'bp': 206156.0, 'sum': 845281.0}, 'ProcedureBlank_14351': {'bp': 198419.0, 'sum': 799333.0}, '5_posi_14352': {'bp': 196353.0, 'sum': 784883.0}, '11_posi_14352': {'bp': 168383.0, 'sum': 629880.0}, '8_posi_14353': {'bp': 147180.0, 'sum': 603590.0}, '6_posi_14355': {'bp': 146459.0, 'sum': 642396.0}, '7_posi_14355': {'bp': 131240.0, 'sum': 545978.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 352.320138
COMMENT: PRECURSOR_M/Z_STDEV 0.000094
COMMENT: PRECURSOR_IN_MS1 mz 352.320848; int 102.137; delta(ppm) 1.381651
COMMENT: PROPOSED_CHARGE_STATE +1; mz 353.324368; int 23.501; cor 0.713
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 369.347383; int 28.260; cor 0.659
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.453; C22H41NO2; [M+H]+; delta(ppm) -0.452587
COMMENT: PROPOSED_MF MS-FINDER 3.111; C22H41NO2; [M+H]+; delta(ppm) -0.451268
COMMENT: PROPOSED_MF SIRIUS5_Sirius 46.714; C22H41NO2; [M+H]+; delta(ppm) -0.451268
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C22H41NO2; [M+H]+; delta(ppm) -0.451268
COMMENT: PROPOSED_MF SIRIUS6_Sirius 80.636; C22H41NO2; [M+H]+; delta(ppm) -0.451268
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.112; C15H38FN7O; [M+H]+; delta(ppm) 3.927351
COMMENT: PROPOSED_MF SIRIUS6_Sirius 48.120; C20H39N4O; [M+H]+; delta(ppm) 3.359655
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.266; C18H37N7; [M+H]+; delta(ppm) 7.170606
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.593; C14H40N8P; [M+H]+; delta(ppm) 6.293260
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.919; C10H35N14; [M+H]+; delta(ppm) -9.484594
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C22H41NO2; [M+H]+; delta(ppm) -0.451268
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.088; WNUBUTOHRXXFPP-UHFFFAOYSA-N; [M+H]+; O=C(O)CC1(CCCC1)CC(CNC)CCCC=CCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.996; MWQCBVWCBTUPDQ-HZJYTTRNSA-N; [M+H]+; CCCCC\C=C/C\C=C/CCCCCCCCCC(=O)NCCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.924; SGGSVIZFYOSMRF-UHFFFAOYSA-N; [M+H]+; CCCCCCC(=O)CCCCCCCCCCC(=O)N1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.784; OJXDYMBOPUDWKQ-UHFFFAOYSA-N; [M+H]+; O=C(O)CC1(CCCC1)C(CCN)CCCCC=CCCCCCC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.420; OJXDYMBOPUDWKQ-UHFFFAOYSA-N; [M+H]+; 2-[1-(1-azaniumylpentadec-8-en-3-yl)cyclopentyl]acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.181; WNUBUTOHRXXFPP-UHFFFAOYSA-N; [M+H]+; 2-(1-{2-[(methylamino)methyl]tridec-6-en-1-yl}cyclopentyl)acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.123; MWQCBVWCBTUPDQ-HZJYTTRNSA-N; [M+H]+; N-(11Z,14Z)-eicosadienoylethanolamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.608; SGGSVIZFYOSMRF-UHFFFAOYSA-N; [M+H]+; UNPD63141
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OJXDYMBOPUDWKQ-UHFFFAOYSA-N; [M+H]+; 2-[1-(1-azaniumylpentadec-8-en-3-yl)cyclopentyl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.267; MWQCBVWCBTUPDQ-HZJYTTRNSA-N; [M+H]+; N-(11Z,14Z)-eicosadienoylethanolamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.216; WNUBUTOHRXXFPP-UHFFFAOYSA-N; [M+H]+; 2-(1-{2-[(methylamino)methyl]tridec-6-en-1-yl}cyclopentyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.149; SGGSVIZFYOSMRF-UHFFFAOYSA-N; [M+H]+; UNPD63141
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.785; HCIRJRYSFLWMMS-ZHACJKMWSA-N; [M+H]+; [2-[(E)-heptadec-8-enyl]-4-methyl-5H-1,3-oxazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.006; JIRWJUZXPJJMAO-UHFFFAOYSA-N; [M+H]+; 1-(1-adamantylmethoxy)-3-(octylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.993; HFDZAMYXLQSMOA-UHFFFAOYSA-N; [M+H]+; 1-(1-adamantylmethoxy)-3-[di(butan-2-yl)amino]propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.874; MGDPVZPFGTZDIP-LCAIAVFMSA-N; [M+H]+; 1-(tert-butylamino)-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -12.376; MWQCBVWCBTUPDQ; [M+H]+; Anandamide (20:2, n-6)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.656; RZLQCNYCMRDLBA; [M+H]+; 4-Oleoylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.504; SGGSVIZFYOSMRF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.072; HCIRJRYSFLWMMS; [M+H]+; Methyl hydroxymethyl oleyl oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.756; OJXDYMBOPUDWKQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.142; JIRWJUZXPJJMAO; [M+H]+; 1-(1-Adamantylmethoxy)-3-octylamino-2-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.480; WNUBUTOHRXXFPP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -357.003; HFDZAMYXLQSMOA; [M+H]+; 1-(1-Adamantylmethoxy)-3-(di-2-butylamino)-2-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.546; MWQCBVWCBTUPDQ; [M+H]+; Anandamide (20:2, n-6)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -49.106; MWQCBVWCBTUPDQ; [M+H]+; N-(2-hydroxyethyl)icosa-11,14-dienamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.647; SGGSVIZFYOSMRF; [M+H]+; 1-(pyrrolidin-1-yl)octadecane-1,12-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -221.421; RZLQCNYCMRDLBA; [M+H]+; 1-Morpholin-4-yloctadec-9-en-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -281.953; IMDOZEUBLKJMFF; [M+H]+; 4-Oxazolinemethanol, 2-heptadecenyl-4-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -298.488; HCIRJRYSFLWMMS; [M+H]+; 4-Oxazolemethanol, 2-(8-heptadecen-1-yl)-4,5-dihydro-4-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -323.842; OJXDYMBOPUDWKQ; [M+H]+; 2-[1-(1-azaniumylpentadec-8-en-3-yl)cyclopentyl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -336.038; WNUBUTOHRXXFPP; [M+H]+; 2-(1-{2-[(methylamino)methyl]tridec-6-en-1-yl}cyclopentyl)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -386.014; JIRWJUZXPJJMAO; [M+H]+; 1-(1-Adamantylmethoxy)-3-octylamino-2-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -436.161; HFDZAMYXLQSMOA; [M+H]+; 1-(1-Adamantylmethoxy)-3-(di-2-butylamino)-2-propanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.739; MWQCBVWCBTUPDQ; [M+H]+; N-(2-hydroxyethyl)icosa-11,14-dienamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, N-(11Z,14Z)-eicosadienoylethanolamine, MWQCBVWCBTUPDQ-HZJYTTRNSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (3), MetFrag:MsfinderDB (2);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C22H41NO2
CH$EXACT_MASS: 351.313730
CH$SMILES: CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)NCCO
CH$IUPAC: InChI=1S/C22H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,24H,2-5,8,11-21H2,1H3,(H,23,25)/b7-6-,10-9-
CH$LINK: CHEBI CHEBI:73733
CH$NAME: N-(11Z,14Z)-eicosadienoylethanolamine
CH$NAME: (11Z,14Z)-N-(2-hydroxyethyl)icosa-11,14-dienamide
CH$LINK: INCHIKEY MWQCBVWCBTUPDQ-HZJYTTRNSA-N
CH$LINK: LIPIDMAPS LMFA08040002
CH$LINK: PUBCHEM CID:5283444
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 28.819
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 352.320847
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0f79-1109000000-e62d7753f49c4a1ebadb
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  67.0542010 35.5652 67.054837 1.5361 6.56 0.9165 14 f{C5H7}/-0.38ppm,p-C17H35N1O2
  81.0698810 100.7318 81.070407 1.1102 20.12 0.8260 17 f{C6H9}/0.05ppm,p-C16H33N1O2
  83.0855035 43.1103 83.086007 1.3480 12.00 0.7882 16 f{C6H11}/-0.28ppm,p-C16H31N1O2
  95.0855515 137.0251 95.085911 1.1148 22.40 0.8750 17 f{C7H11}/0.26ppm,p-C15H31N1O2
  97.1011817 46.4132 97.101527 2.0803 12.32 0.7426 17 f{C7H13}/0.05ppm,p-C15H29N1O2
  109.1012004 118.9154 109.101437 1.2007 14.74 0.9069 17 f{C8H13}/0.22ppm,p-C14H29N1O2
  121.1011717 43.3557 121.101267 2.0809 9.81 0.7917 17 f{C9H13}/-0.04ppm,p-C13H29N1O2
  123.1169603 101.4452 123.117029 1.1128 18.93 0.9191 17 f{C9H15}/1.08ppm,p-C13H27N1O2
  135.1169575 43.5560 135.116865 2.1093 14.18 0.7670 14 f{C10H15}/0.97ppm,p-C12H27N1O2
  137.1325626 68.2110 137.132469 1.7355 15.32 0.6789 17 f{C10H17}/0.62ppm,p-C12H25N1O2
  149.1325428 46.7515 149.132441 2.2866 12.92 0.7265 16 f{C11H17}/0.44ppm,p-C11H25N1O2
  271.2418689 66.3657 271.241692 2.0203 25.91 0.5098 17 f{C20H31}/-0.58ppm,p-C2H11N1O2
  289.2535243 39.1145 289.253337 2.7657 15.77 0.1399 12 f{C20H33O1}/3.22ppm,p-C2H9N1O1
  299.2731099 64.6784 299.272917 2.9238 12.84 0.8873 17 f{C22H35}/-0.73ppm,p-H7N1O2
  317.2840572 214.6700 317.283854 1.9068 29.17 0.9436 17 f{C22H37O1}/0.52ppm,p-H5N1O1
  334.3107586 82.8359 334.310545 1.9174 20.87 0.7623 17 f{C22H40N1O1}/0.95ppm,p-H2O1
  335.2942680 999.0000 335.294054 0.3907 0.00 0.9559 17 f{C22H39O2}/-0.56ppm,p-H3N1
  352.2440702 182.5661 352.243847 3.8610 62.30 0.4412 16 ?
  352.2805780 135.8669 352.280355 1.7429 55.11 0.2843 17 ?
  352.3205433 444.5390 352.320320 1.9301 44.41 1.0000 17 f{C22H42N1O2}/-1.31ppm,p
  352.3581787 92.4751 352.357955 2.7103 59.35 -0.7527 13 ?
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  67.054201 35.57 35
  81.069881 100.73 100
  83.085504 43.11 43
  95.085552 137.03 137
  97.101182 46.41 46
  109.101200 118.92 118
  121.101172 43.36 43
  123.116960 101.45 101
  135.116958 43.56 43
  137.132563 68.21 68
  149.132543 46.75 46
  271.241869 66.37 66
  289.253524 39.11 39
  299.273110 64.68 64
  317.284057 214.67 214
  334.310759 82.84 82
  335.294268 999.00 999
  352.244070 182.57 182
  352.280578 135.87 135
  352.320543 444.54 444
  352.358179 92.48 92
//
